FDA pushes to remove pregnancy drug, company pushes back
The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market.
The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market.